vs
Creative Media & Community Trust Corp（CMCT）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
Creative Media & Community Trust Corp的季度营收约是STANDARD BIOTOOLS INC.的1.5倍（$28.5M vs $19.6M），Creative Media & Community Trust Corp净利率更高（-125.8% vs -177.4%，领先51.7%），Creative Media & Community Trust Corp同比增速更快（3.6% vs -11.5%），过去两年Creative Media & Community Trust Corp的营收复合增速更高（-8.5% vs -12.2%）
Creative Media & Community Trust Corp是一家总部位于美国的房地产投资信托企业，核心运营两大板块：持有、管理及开发专业影视制作工作室等创意媒体设施，以及经济适用房、社区医疗中心、邻里商业空间等民生类物业，服务传媒客户及各地社区居民。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
CMCT vs LAB — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $28.5M | $19.6M |
| 净利润 | $-11.4M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -125.6% | -168.5% |
| 净利率 | -125.8% | -177.4% |
| 营收同比 | 3.6% | -11.5% |
| 净利润同比 | -11.4% | -28.8% |
| 每股收益（稀释后） | $-3.89 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $28.5M | — | ||
| Q3 25 | $26.2M | $19.6M | ||
| Q2 25 | $29.7M | $21.8M | ||
| Q1 25 | $32.3M | $40.8M | ||
| Q4 24 | $27.5M | — | ||
| Q3 24 | $28.6M | $22.1M | ||
| Q2 24 | $34.4M | $22.5M | ||
| Q1 24 | $34.0M | $45.5M |
| Q4 25 | $-11.4M | — | ||
| Q3 25 | $-12.5M | $-34.7M | ||
| Q2 25 | $-9.0M | $-33.5M | ||
| Q1 25 | $-6.1M | $-26.0M | ||
| Q4 24 | $-10.3M | — | ||
| Q3 24 | $-10.4M | $-26.9M | ||
| Q2 24 | $-796.0K | $-45.7M | ||
| Q1 24 | $-3.7M | $-32.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
| Q4 25 | -125.6% | — | ||
| Q3 25 | -47.7% | -168.5% | ||
| Q2 25 | -30.3% | -118.1% | ||
| Q1 25 | -19.0% | -80.8% | ||
| Q4 24 | -128.8% | — | ||
| Q3 24 | -36.9% | -120.9% | ||
| Q2 24 | -1.6% | -134.5% | ||
| Q1 24 | -10.7% | -132.2% |
| Q4 25 | -125.8% | — | ||
| Q3 25 | -47.5% | -177.4% | ||
| Q2 25 | -30.3% | -153.7% | ||
| Q1 25 | -18.9% | -63.8% | ||
| Q4 24 | -129.8% | — | ||
| Q3 24 | -36.3% | -122.0% | ||
| Q2 24 | -2.3% | -203.3% | ||
| Q1 24 | -11.0% | -70.6% |
| Q4 25 | $-3.89 | — | ||
| Q3 25 | $-23.52 | $-0.09 | ||
| Q2 25 | $-18.94 | $-0.09 | ||
| Q1 25 | $-20.73 | $-0.07 | ||
| Q4 24 | $97.71 | — | ||
| Q3 24 | $-305.04 | $-0.07 | ||
| Q2 24 | $-98.64 | $-0.12 | ||
| Q1 24 | $-125.46 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.4M | $129.4M |
| 总债务越低越好 | $509.8M | — |
| 股东权益账面价值 | $265.4M | $399.7M |
| 总资产 | $859.2M | $539.6M |
| 负债/权益比越低杠杆越低 | 1.92× | — |
8季度趋势，按日历期对齐
| Q4 25 | $15.4M | — | ||
| Q3 25 | $17.3M | $129.4M | ||
| Q2 25 | $27.8M | $158.6M | ||
| Q1 25 | $19.8M | $150.9M | ||
| Q4 24 | $20.3M | — | ||
| Q3 24 | $18.5M | $210.6M | ||
| Q2 24 | $29.3M | $269.8M | ||
| Q1 24 | $21.3M | $287.1M |
| Q4 25 | $509.8M | — | ||
| Q3 25 | $527.8M | — | ||
| Q2 25 | $535.6M | — | ||
| Q1 25 | $512.7M | — | ||
| Q4 24 | $505.7M | — | ||
| Q3 24 | $478.3M | $55.2M | ||
| Q2 24 | $485.1M | $55.1M | ||
| Q1 24 | $472.8M | $55.0M |
| Q4 25 | $265.4M | — | ||
| Q3 25 | $281.9M | $399.7M | ||
| Q2 25 | $287.1M | $424.5M | ||
| Q1 25 | $293.0M | $454.6M | ||
| Q4 24 | $304.5M | — | ||
| Q3 24 | $321.0M | $489.3M | ||
| Q2 24 | $351.1M | $510.3M | ||
| Q1 24 | $369.9M | $577.3M |
| Q4 25 | $859.2M | — | ||
| Q3 25 | $871.8M | $539.6M | ||
| Q2 25 | $885.0M | $557.0M | ||
| Q1 25 | $882.3M | $579.6M | ||
| Q4 24 | $889.6M | — | ||
| Q3 24 | $868.0M | $681.5M | ||
| Q2 24 | $891.2M | $708.7M | ||
| Q1 24 | $887.5M | $777.7M |
| Q4 25 | 1.92× | — | ||
| Q3 25 | 1.87× | — | ||
| Q2 25 | 1.87× | — | ||
| Q1 25 | 1.75× | — | ||
| Q4 24 | 1.66× | — | ||
| Q3 24 | 1.49× | 0.11× | ||
| Q2 24 | 1.38× | 0.11× | ||
| Q1 24 | 1.28× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
| Q4 25 | $5.8M | — | ||
| Q3 25 | $3.7M | $-22.2M | ||
| Q2 25 | $-2.5M | $-20.7M | ||
| Q1 25 | $1.2M | $-30.3M | ||
| Q4 24 | $17.0M | — | ||
| Q3 24 | $10.3M | $-27.9M | ||
| Q2 24 | $3.9M | $-39.0M | ||
| Q1 24 | $1.6M | $-62.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CMCT
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
